Bioventus reports Q2 adjusted EPS 19c, consensus 7c
PremiumThe FlyBioventus reports Q2 adjusted EPS 19c, consensus 7c
2M ago
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
Premium
Press Releases
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
2M ago
Envoy Medical appoints Michael Crowe to board of directors
Premium
The Fly
Envoy Medical appoints Michael Crowe to board of directors
3M ago
Bioventus reports Q1 EPS (7c) vs ($2.24) last year
PremiumThe FlyBioventus reports Q1 EPS (7c) vs ($2.24) last year
5M ago
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Premium
Press Releases
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
5M ago
Bioventus price target raised to $9 from $6 at Craig-Hallum
Premium
The Fly
Bioventus price target raised to $9 from $6 at Craig-Hallum
6M ago
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesBioventus Announces Fourth Quarter and Full Year 2023 Financial Results
6M ago
Bioventus reports Q4 adjusted EPS 7c, consensus 2c
Premium
The Fly
Bioventus reports Q4 adjusted EPS 7c, consensus 2c
6M ago
Bioventus Amends Credit Agreement with Enhanced Covenants
Premium
Market News
Bioventus Amends Credit Agreement with Enhanced Covenants
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100